Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Mar;69(3):617–631. doi: 10.1172/JCI110489

Selective Protection against Conidia by Mononuclear and against Mycelia by Polymorphonuclear Phagocytes in Resistance to Aspergillus

OBSERVATIONS ON THESE TWO LINES OF DEFENSE IN VIVO AND IN VITRO WITH HUMAN AND MOUSE PHAGOCYTES

Andreas Schaffner 1,2, Herndon Douglas 1,2, Abraham Braude 1,2
PMCID: PMC371019  PMID: 7037853

Abstract

By comparing natural immunity to Aspergillus fumigatus (AF) in vivo with the action of human or mouse phagocytes against AF in vitro, we delineated two sequential lines of defense against AF. The first line of defense was formed by macrophages and directed against spores. Macrophages prevented germination and killed spores in vitro and rapidly eradicated conidia in vivo, even in neutropenic and athymic mice. The second was the neutrophilic granulocyte (PMN), which protected against the hyphal form of AF. Human and mouse PMN killed mycelia in vitro. Normal, but not neutropenic mice, stopped hyphal growth, and eradicated mycelia. Either line of defense acting alone protected mice from high challenge doses. Natural immunity collapsed only when both the reticuloendothelial system and PMN were impaired. These findings are in keeping with the clinical observation that high doses of cortisone and neutropenia are the main risk factors for invasive aspergillosis. Cortisone inhibited the conidiacidal activity of mouse macrophages in vivo and of human or mouse mononuclear phagocytes in vitro. Cortisone damaged this first line of defense directly and not through the influence of T lymphocytes or other systems modifying macrophage function as shown in athymic mice and in vitro. In addition, daily high doses of cortisone in mice reduced the mobilization of PMN so that the second line of defense was also impaired. Thus, cortisone can break down natural resistance on its own. Myelosuppression rendered mice susceptible only when the first line of defense was overpowered by high challenge doses, by activated spores that cannot be killed by macrophages, or by cortisone suppression of the conidiacidal activity of macrophages.

The host, thus, can call upon two independent phagocytic cell lines that form graded defense systems against aspergillus. These lines of defense function in the absence of a specific immune response, which seems superfluous in the control and elimination of this fungus.

Full text

PDF
617

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKER O., BRAUDE A. I. A study of stimuli leading to the production of spherules in coccidioidomycosis. J Lab Clin Med. 1956 Feb;47(2):169–181. [PubMed] [Google Scholar]
  2. Babior B. M. Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med. 1978 Mar 30;298(13):721–725. doi: 10.1056/NEJM197803302981305. [DOI] [PubMed] [Google Scholar]
  3. Bach M. C., Adler J. L., Breman J., P'eng F. K., Sahyoun A., Schlesinger R. M., Madras P., Monaco A. P. Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet. 1973 Jan 27;1(7796):180–184. doi: 10.1016/s0140-6736(73)90007-x. [DOI] [PubMed] [Google Scholar]
  4. Beaman L., Holmberg C. A. In vitro response of alveolar macrophages to infection with Coccidioides immitis. Infect Immun. 1980 May;28(2):594–600. doi: 10.1128/iai.28.2.594-600.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burton J. R., Zachery J. B., Bessin R., Rathbun H. K., Greenough W. B., 3rd, Sterioff S., Wright J. R., Slavin R. E., Williams G. M. Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B. Ann Intern Med. 1972 Sep;77(3):383–388. doi: 10.7326/0003-4819-77-3-383. [DOI] [PubMed] [Google Scholar]
  6. Bøyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol. 1976 Jun;Suppl 5:9–15. [PubMed] [Google Scholar]
  7. Corbel M. J., Eades S. M. Examination of the effect of age and acquired immunity on the susceptibility of mice to infection with Aspergillus fumigatus. Mycopathologia. 1977 Feb 18;60(2):79–85. doi: 10.1007/BF00490376. [DOI] [PubMed] [Google Scholar]
  8. Diamond R. D., Krzesicki R., Epstein B., Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol. 1978 May;91(2):313–328. [PMC free article] [PubMed] [Google Scholar]
  9. Epstein S. M., Verney E., Miale T. D., Sidransky H. Studies on the pathogenesis of experimental pulmonary aspergillosis. Am J Pathol. 1967 Nov;51(5):769–788. [PMC free article] [PubMed] [Google Scholar]
  10. Fauci A. S., Dale D. C., Balow J. E. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976 Mar;84(3):304–315. doi: 10.7326/0003-4819-84-3-304. [DOI] [PubMed] [Google Scholar]
  11. Fauci A. S., Dale D. C. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest. 1974 Jan;53(1):240–246. doi: 10.1172/JCI107544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ford S., Friedman L. Experimental study of the pathogenicity of aspergilli for mice. J Bacteriol. 1967 Oct;94(4):928–933. doi: 10.1128/jb.94.4.928-933.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Greenberg D., Ammann A. J., Wara D. W., Kaltreider H. B. Immunity to Aspergillus in patients with chronic granulomatous disease. J Pediatr. 1977 Apr;90(4):601–603. doi: 10.1016/s0022-3476(77)80377-6. [DOI] [PubMed] [Google Scholar]
  14. Ito J. I., Jr, Wunderlich A. C., Lyons J., Davis C. E., Guiney D. G., Braude A. I. Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae. J Infect Dis. 1980 Oct;142(4):532–537. doi: 10.1093/infdis/142.4.532. [DOI] [PubMed] [Google Scholar]
  15. Kong Y. C., Levine H. B. Experimentally induced immunity in the mycoses. Bacteriol Rev. 1967 Mar;31(1):35–53. doi: 10.1128/br.31.1.35-53.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lazarus G. M., Neu H. C. Agents responsible for infection in chronic granulomatous disease of childhood. J Pediatr. 1975 Mar;86(3):415–417. doi: 10.1016/s0022-3476(75)80975-9. [DOI] [PubMed] [Google Scholar]
  17. Lehrer R. I., Jan R. G. Interaction of Aspergillus fumigatus Spores with Human Leukocytes and Serum. Infect Immun. 1970 Apr;1(4):345–350. doi: 10.1128/iai.1.4.345-350.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Merkow L. P., Epstein S. M., Sidransky H., Verney E., Pardo M. The pathogenesis of experimental pulmonary aspergillosis. An ultrastructural study of alveolar macrophages after phagocytosis of a flavus spores in vivo. Am J Pathol. 1971 Jan;62(1):57–74. [PMC free article] [PubMed] [Google Scholar]
  19. Merkow L., Pardo M., Epstein S. M., Verney E., Sidransky H. Lysosomal stability during phagocytosis of Aspergillus flavus spores by alveolar macrophages of cortisone-treated mice. Science. 1968 Apr 5;160(3823):79–81. doi: 10.1126/science.160.3823.79. [DOI] [PubMed] [Google Scholar]
  20. Meyer R. D., Young L. S., Armstrong D., Yu B. Aspergillosis complicating neoplastic disease. Am J Med. 1973 Jan;54(1):6–15. doi: 10.1016/0002-9343(73)90077-6. [DOI] [PubMed] [Google Scholar]
  21. PETERSON R. E., WYNGAARDEN J. B., GUERRA S. L., BRODIE B. B., BUNIM J. J. The physiological disposition and metabolic fate of hydrocortisone in man. J Clin Invest. 1955 Dec;34(12):1779–1794. doi: 10.1172/JCI103233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. PIGGOTT W. R., EMMONS C. W. Device for inhalation exposure of animals to spores. Proc Soc Exp Biol Med. 1960 Apr;103:805–806. doi: 10.3181/00379727-103-25677. [DOI] [PubMed] [Google Scholar]
  23. PORTER C. C., SILBER R. H. The absorption and glycogenic activity of cortisone and hydrocortisone after parenteral administration to rats. Endocrinology. 1953 Jul;53(1):73–78. doi: 10.1210/endo-53-1-73. [DOI] [PubMed] [Google Scholar]
  24. Rinehart J. J., Balcerzak S. P., Sagone A. L., LoBuglio A. F. Effects of corticosteroids on human monocyte function. J Clin Invest. 1974 Dec;54(6):1337–1343. doi: 10.1172/JCI107880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rinehart J. J., Sagone A. L., Balcerzak S. P., Ackerman G. A., LoBuglio A. F. Effects of corticosteroid therapy on human monocyte function. N Engl J Med. 1975 Jan 30;292(5):236–241. doi: 10.1056/NEJM197501302920504. [DOI] [PubMed] [Google Scholar]
  26. Rippon J. W., Anderson D. N. Experimental mycosis in immunosuppressed rabbits. II. Acute and chronic aspergillosis. Mycopathologia. 1978 Oct 16;64(2):97–100. doi: 10.1007/BF00440968. [DOI] [PubMed] [Google Scholar]
  27. Rose H. D. Mechanical control of hospital ventilation and Aspergillus infections. Am Rev Respir Dis. 1972 Feb;105(2):306–307. doi: 10.1164/arrd.1972.105.2.306. [DOI] [PubMed] [Google Scholar]
  28. Rubin R. H., Wolfson J. S., Cosimi A. B., Tolkoff-Rubin N. E. Infection in the renal transplant recipient. Am J Med. 1981 Feb;70(2):405–411. doi: 10.1016/0002-9343(81)90780-4. [DOI] [PubMed] [Google Scholar]
  29. SIDRANSKY H., FRIEDMAN L. The effect of cortisone and antibiotic agents on experimental pulmonary aspergillosis. Am J Pathol. 1959 Jan-Feb;35(1):169–183. [PMC free article] [PubMed] [Google Scholar]
  30. SIDRANSKY H., VERNEY E., BEEDE H. EXPERIMENTAL PULMONARY ASPERGILLOSIS. Arch Pathol. 1965 Mar;79:299–309. [PubMed] [Google Scholar]
  31. Sidransky H., Epstein S. M., Verney E., Horowitz C. Experimental visceral aspergillosis. Am J Pathol. 1972 Oct;69(1):55–70. [PMC free article] [PubMed] [Google Scholar]
  32. Turner K. J., Hackshaw R., Papadimitriou J., Perrott J. The pathogenesis of experimental pulmonary aspergillosis in normal and cortisone-treated rats. J Pathol. 1976 Feb;118(2):65–73. doi: 10.1002/path.1711180202. [DOI] [PubMed] [Google Scholar]
  33. Turner K. J., Hackshaw R., Papadimitriou J., Wetherall J. D., Perrott J. Experimental aspergillosis in rats infected via intraperitoneal and subcutaneous routes. Immunology. 1975 Jul;29(1):55–66. [PMC free article] [PubMed] [Google Scholar]
  34. White L. O. Germination of Aspergillus fumigatus conidia in the lungs of normal and cortisone-treated mice. Sabouraudia. 1977 Mar;15(1):37–41. [PubMed] [Google Scholar]
  35. Young R. C., Bennett J. E., Vogel C. L., Carbone P. P., DeVita V. T. Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 1970 Mar;49(2):147–173. doi: 10.1097/00005792-197003000-00002. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES